Details of the Drug

General Information of Drug (ID: DMG0Y0T)

Drug Name

BIOVANCE

Indication

Disease Entry	ICD 11	Status	REF
Wound healing	EL8Y	Phase 4	[1]
------------------------------------------------------------------------------------

Cross-matching ID

References

1	ClinicalTrials.gov (NCT02521402) Pilot Study to Evaluate Clinical Outcomes With the Use of Biovance Following Keloid Scar Revision Surgery.